Puma Biotechnology, Inc. - Laporan Laba Rugi (TTM)

Puma Biotechnology, Inc.
US ˙ NasdaqGS ˙ US74587V1070

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Puma Biotechnology, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 235 225 272 255 250 253 201 207 218 228 235 230 229 236 227 219 244 230 233 238
Change (%) -4.40 20.86 -6.32 -1.77 1.12 -20.71 3.06 5.25 4.74 3.09 -2.11 -0.43 2.84 -3.82 -3.30 11.15 -5.38 0.97 2.30
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 39 39 40 42 43 64 45 48 50 55 57 54 55 63 60 59 75 64 64 66
Change (%) 2.07 1.22 6.41 0.79 49.02 -29.38 6.55 4.62 9.85 4.31 -5.33 1.45 13.56 -3.97 -1.99 26.80 -13.91 -0.27 2.56
% of Revenue 16.38 17.49 14.65 16.64 17.07 25.16 22.41 23.17 23.04 24.16 24.45 23.64 24.09 26.60 26.56 26.92 30.71 27.94 27.60 27.67
Gross Operating Profit 197 186 232 212 208 189 156 159 168 173 178 176 174 173 166 160 169 166 168 172
Change (%) -5.67 25.02 -8.51 -2.28 -8.74 -17.80 2.05 5.44 3.21 2.70 -1.06 -1.01 -0.57 -3.77 -3.78 5.38 -1.60 1.45 2.20
% of Revenue 83.62 82.51 85.35 83.36 82.93 74.84 77.59 76.83 76.96 75.84 75.55 76.36 75.91 73.40 73.44 73.08 69.29 72.06 72.40 72.33
SG&A 120 118 116 126 122 116 108 90 87 90 94 98 97 89 89 89 83 80 76 69
Change (%) -1.18 -2.28 8.78 -2.79 -5.02 -6.74 -17.46 -2.37 2.95 4.54 4.13 -1.18 -7.73 -0.82 0.58 -6.72 -3.53 -5.17 -9.11
% of Revenue 50.92 52.64 42.56 49.42 48.91 45.94 54.03 43.28 40.15 39.46 40.01 42.56 42.24 37.90 39.08 40.65 34.12 34.78 32.67 29.02
R&D 104 98 92 86 82 72 67 60 53 52 50 51 51 50 51 52 53 55 55 57
Change (%) -5.86 -5.35 -6.55 -5.22 -12.21 -6.94 -9.98 -12.59 -0.73 -4.84 2.80 0.38 -1.78 1.75 0.54 2.14 4.36 0.50 3.30
% of Revenue 44.05 43.38 33.97 33.89 32.70 28.39 33.32 29.11 24.17 22.91 21.15 22.21 22.39 21.38 22.62 23.52 21.61 23.84 23.73 23.96
OpEx 262 256 248 255 247 252 220 198 190 197 201 203 203 202 200 200 211 200 195 192
Change (%) -2.55 -2.91 2.69 -3.02 1.95 -12.52 -10.28 -3.79 3.75 1.99 1.10 -0.09 -0.44 -1.16 -0.21 5.48 -5.24 -2.03 -1.77
% of Revenue 111.35 113.51 91.18 99.95 98.68 99.49 109.77 95.56 87.35 86.53 85.61 88.41 88.71 85.88 88.26 91.09 86.44 86.56 83.99 80.65
Operating Income -27 -30 24 0 3 1 -20 9 28 31 34 27 26 33 27 20 33 31 37 46
Change (%) 13.72 -178.93 -99.45 2,406.82 -61.02 -1,619.61 -146.88 199.66 11.56 10.13 -21.18 -3.03 28.64 -20.03 -26.58 69.09 -6.23 20.29 23.67
% of Revenue -11.35 -13.51 8.82 0.05 1.32 0.51 -9.77 4.44 12.65 13.47 14.39 11.59 11.29 14.12 11.74 8.91 13.56 13.44 16.01 19.35
Interest Expense -14 -14 -14 -14 -14 -13 -12 -11 -11 -12 -12 -13 -13 -13 -13 -13 -13 -12 -11 -10
Change (%) 3.62 2.72 -1.84 -3.57 -6.22 -6.14 -6.79 -1.55 5.09 5.59 5.09 3.05 0.57 0.35 0.35 -1.78 -5.56 -9.49 -13.62
% of Revenue -5.76 -6.24 -5.30 -5.56 -5.45 -5.06 -5.99 -5.42 -5.07 -5.08 -5.21 -5.59 -5.78 -5.66 -5.90 -6.13 -5.41 -5.40 -4.84 -4.09
Net Income -56 -60 -27 -35 -48 -29 -49 -34 10 0 5 -2 4 22 15 9 23 30 38 48
Change (%) 6.75 -55.77 32.42 37.59 -39.75 68.43 -29.71 -128.52 -99.98 240,200.00 -150.75 -252.40 480.87 -28.79 -43.28 166.53 30.28 25.72 27.28
% of Revenue -23.87 -26.65 -9.75 -13.79 -19.31 -11.51 -24.44 -16.67 4.52 0.00 2.04 -1.06 1.62 9.16 6.78 3.98 9.54 13.14 16.36 20.35

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista